The Mouse CD22 Monoclonal Antibody (Biotin Conjugated) - Clone: Cy34.1 (AGEL0124) is an essential tool for researchers investigating CD22 expression and function in various biological contexts. CD22 is a cell surface glycoprotein primarily found on B cells and plays a crucial role in regulating B cell activation and signaling.This monoclonal antibody, produced using the Cy34.1 clone, offers high specificity and sensitivity for detecting CD22 in mouse samples. The biotin conjugation provides an easy and efficient means of detection using common laboratory techniques such as immunohistochemistry, flow cytometry, and ELISA.By targeting CD22, researchers can gain valuable insights into B cell biology, immune responses, and potential therapeutic strategies for conditions involving B cell dysfunction.
The use of this monoclonal antibody facilitates precise and reliable detection of CD22, aiding in the study of autoimmune diseases, lymphomas, leukemias, and other conditions where B cells and their regulation are implicated.For accurate and reproducible results in your experiments focusing on B cell function and related diseases, the Mouse CD22 Monoclonal Antibody (Biotin Conjugated) - Clone: Cy34.1 (AGEL0124) is an indispensable reagent that can elevate the quality of your research outcomes.
Each lot of this antibody is quality control tested by flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Swissprot:
P35329
Gene ID:
12483
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
The Cy34.1 monoclonal antibody specifically binds to the B-lymphocyte differentiation antigen CD22 on strains having the Lyb-8.2 alloantigen (e.g., A, BALB/c, CBA, C3H/He, C57BL, C57L, C58, SJL, SWR, but not AKR, DBA/1, DBA/2, NZB, PL). CD22 is expressed at high levels on mature peripheral B lymphocytes (follicular and marginal zone), B-1 cells (CD5+ B cells), and plasma cells. It is a member of the Ig gene superfamily and associates with the B-cell antigen receptor. Its sialic acid- binding immunoglobulin-like lectin (siglec) extracellular region mediates B-cell adhesion to ligands on endothelial cells in the bone marrow. Its intracellular domain is phosphorylated after cross-linking of antigen receptor or MHC class II antigen. It is involved in negative regulation of B-cell activation and protection from autoimmunity. B-cell proliferative responses to LPS or anti-mouse Ig µ chain are augmented in the presence of Cy34.1 mAb.